Genome Therapeutics And ICAgen Collaborate To Conduct Drug Target Analysis

. and , Inc. have announced an agreement that utilizes Genome Therapeutics’ technology to facilitate the assessment and development of a clinical trial design protocol for one of ICAgen’s ion channel targets.

The genomics technology utilizes polymorphism analysis in subgroups of the target patient population to rapidly determine the target’s efficacy and thus quickly assess its likelihood for clinical success.

The ICAgen ion channel target under analysis belongs to an attractive class of therapeutic targets that play a critical role in regulating the flow of electrolytes, such as potassium, sodium and calcium, in and out of cells.

As part of this pharmacogenomics collaboration, Genome Therapeutics will use its proprietary sequence-based polymorphism detection platform to analyze inter-individual variation and determine genetic polymorphisms which could impact protein structure and function.

This technology allows the identification of SNPs (single nucleotide polymorphisms), as well as deletions, insertions or re- arrangements in the gene region.

Genome Therapeutics will also develop a unique detection system for the drug target, which will be used to perform rapid sequence analysis of the essential regions of the gene using genomic DNA from a statistically relevant panel of individuals.

This analysis will help ICAgen in understanding the relationship of genetic polymorphisms to specific drug efficacy and increase the potential for clinical success.

“It has become essential to consider human variation and individuality in all drug development efforts – from target selection through clinical development of new products,” said Dr. Richard D. Gill, President and Chief Operating Officer of Genome Therapeutics.

“ICAgen clearly appreciates the benefits of utilizing genomics for early target analysis to help mitigate the risks associated with clinical trial design.”

“We welcome the opportunity to collaborate with Genome Therapeutics and believe that the quality of their work will ensure the detection and accuracy of genetic variations and will continue to increase the probability of ICAgen’s pharmaceutical success,” said P. Kay Wagoner, Ph.D., President and CEO of ICAgen.

“As a rapidly- growing biopharmaceutical company with multiple opportunities for clinical development, we will utilize technologies that can increase the efficiency of clinical development and accelerate or refine the clinical trial process.”

This collaboration is an early application of Genome Therapeutics’ broad array of genomics-based tools and technologies employed in its pharmacogenomics business, which can be used in collaboration with all sizes of pharmaceutical companies to improve the efficiency of their drug discovery programs, from target selection through clinical trial design and trial repositioning, to rescuing post-marketing product failures.


Dragon Pharma operates four separate pharmacy businesses from its location in Europe. They offer in-store and mail order steroids: Trenbolone 100.

Buying Dragon Pharma LLC of Top Quality

Winstrol Tabs - Discount Price

Administration: Oral
Active Ingredient: Stanozolol
Manufacturer: Dragon Pharmaceutical
Unit: 30 x 100 tablets (50 mg/tab)
Price: 30 x $53.00

Sustanon 350

Injectable Anabolic Steroid
Principal Component: Testosterone Blend
Produced by: Dragon Pharmaceutical
Unit: 1 X 10 ml (350 mg/ml)

NPP 150

Injectable Anabolic Steroid
Main Chemical Name: Nandrolone Phenylpropionate
Manufacturer: Dragon Pharma
Package: 1 X 10 ml (150 mg/ml)

Winstrol Tabs - Cheap Price

Administration: Oral
Basal Substance: Stanozolol
Branded by: Dragon Pharma Labs
Amount: 20 x 100 pills (50 mg/tab)
Price: 20 x $58.00


Synthetic Anabolic Steroidal Agent
Active Substance: Oxymetholone
Branded by: Dragon Pharmaceutical
Package: 1 X 100 tabs (50 mg/pastille)

Enantat 250 - Bulk Price

Administration: Injection
Primary Component: Testosterone Enanthate
Producer: Dragon Pharma Labs
Pack: 10 x 10 mL vial (250 mg/mL)
Price: 10 x $36.00

Parabolan 100 - Discount Price

Administration: Injection
Main Component: Trenbolone Hexahydrobenzylcarbonate
Produced by: Dragon Pharma Labs
Unit: 30 x 10 mL vial (100 mg/mL)
Price: 30 x $45.00

Dianabol 20 - Cheap Price

Administration: Oral
Principal Component: Methandrostenolone
Made by: Dragon Pharma LLC
Package: 20 x 100 tablets (20 mg/tab)
Price: 20 x $32.00


Selective Estrogen Receptor Modulator
Principal Substance: Clomiphene Citrate
Produced by: Dragon Pharma
Unit: 1 X 100 tablets (50 mg/pastille)

Deca 300 [10 Vials]

Injectable Steroid for Muscle Growth
Active Constituent: Nandrolone Decanoate
Produced by: Dragon Pharmaceuticals
10 Vials [10 mL per Vial (300 mg/ml)]
Price: 10 x $45.00 = $450.00 in Total

Primobolan 200

Injectable Steroid for Muscle Growth
Primary Chemical Name: Methenolone Enanthate
Producer: Dragon Pharmaceutical
10 mL Sterile Multi-dose Vial (200 mg/mL)

Enanthat 250

Injectable Steroid for Muscle Growth
Primary Ingredient: Testosterone Enanthate
Produced by: Dragon Pharma LLC
10 mL Sterile Multi-dose Vial (250 mg/mL)